Searchable abstracts of presentations at key conferences in endocrinology

ea0070s4.3 | Unveiling signatures in pituitary neuroendocrine tumours | ECE2020

Unravelling the PitNET methyloma

Pico Antonio

Context: Pituitary tumorigenesis does not fit into the most common model of cancer development driven by gene mutations. Instead, epigenetic mechanisms have been widely involved. Among them, aberrant DNA methylation at CpG sites is one of epigenetic hallmarks of tumour cells. There are several methods to study the epigenetic regulation of genome activity, from DNA methylation arrays to more specific DNA methylation analysis such as pyrosequencing, Methylation-Specific PCR (MS-...

ea0032s32.2 | Is diabetes a lipid disease? | ECE2013

Fatty liver disease

Moschetta Antonio

Nonalcoholic fatty liver disease (NAFLD) is becoming a master component of the epidemic of obesity and metabolic syndrome worldwide due to excessive caloric intake. The spectrum of NAFLD ranges from simple fatty liver with benign prognosis to a potentially progressive form, nonalcoholic steatohepatitis (NASH), which may lead to liver fibrosis and cirrhosis resulting in increased morbidity and mortality. Development of hepatic steatosis and its progression to steatohepatitis ma...

ea0020s15.2 | Progress in understanding and management of diabetes | ECE2009

The metabolic memory

Ceriello Antonio

Large randomized studies have established that early intensive glycemic control reduces the risk of diabetic complications, both micro and macrovascular. However, epidemiological and prospective data support a long-term influence of early metabolic control on clinical outcomes. This phenomenon has recently been defined as ‘Metabolic Memory.’ It was first hypothesized by Brownlee (Nature 2000), and since shown by many researchers that overproduction of free radicals, ...

ea0015s22 | Thyroid hormones in development: physiology and clinical implications | SFEBES2008

New roles of deiodinases in development

Bianco Antonio

Thyroid hormone 3,5,3′-triiodothyronine (T3) and its precursor thyroxine (T4) are iodinated compounds known to influence gene expression in virtually every vertebrate tissue. Fundamentally, thyroid hormone signaling results from the interaction of nuclear thyroid hormone receptors (TRs) with specific target gene promoters, a process that can either enhance or repress transcription. This process is modulated via binding of thyroid hormone, the ligand...

ea0094pl1.1 | Clinical Endocrinology Trust Visiting Professor Lecture | SFEBES2023

Are we restoring thyroid hormone signaling in patients with hypothyroidism?

Bianco Antonio

The binding of T3 to its nuclear receptors (TR) triggers T3 signaling, modulating the expression of thousands of genes. These events are reversible and fluctuate according to the T3 levels. In developing tissues, T3 signaling also modifies chromatin folding, permanently affecting gene expression throughout life. Hypothyroidism occurs when, at any time, there is insufficient T3 signaling, frequently due to low plasma thyroid hormone levels. The treatment is with levothyroxine (...

ea0027p64 | (1) | BSPED2011

Internet-based information resources for young patients and families with diabetes mellitus: a user preference survey

Hopkins Sarah , Pesterfield Claire , Acerini Carlo

Background: Internet-based education and information resources for young people and families with DM have increased, yet the extent of use and perceived value among this patient group is uncertain. We conducted a questionnaire-based survey of parents’ and carers’ experience of currently available DM internet-based resources.Objective: To assess i) level of internet use, ii) perceived quality of patient support information currently available, i...

ea0023p38 | (1) | BSPED2009

Management of central diabetes insipidus in a paediatric intensive care unit

Babiker Amir , Acerini Carlo , Tasker Robert

Background: Central diabetes insipidus (CDI) is rare in infants and children. Up to 30 percent of cases are idiopathic and its clinical presentation is poorly defined. In critically ill paediatric intensive care unit (PICU) patient with CDI, there is increased risk of brain damage and death due to severe hyperosmolarity, hypovolaemic shock, hypernatraemic seizures or complications of treatment.Aim: To assess the causes, management and outcome of CDI in p...

ea0045p14 | Diabetes | BSPED2016

Identifying the barriers to diagnosing type 1 diabetes in young people in the primary care setting

Suo Chenqu , Wilson Kate , Acerini Carlo

Objectives: In the UK the majority of young people presenting for the first time with signs and symptoms of type 1 diabetes (T1D) are initially seen by general practitioners (GPs). Mis- or delayed diagnosis is not uncommon, and it increases the risk of diabetic ketoacidosis-related morbidity. This study seeks to identify the specific challenges faced by GPs in this setting in order to develop effective care pathways and recommendations for improving the timely diagnosis of T1D...

ea0049gp100 | Diabetes therapy & complications 1 | ECE2017

Type 1 diabetes and hearing loss: a meta-analysis

Mujica-Mota Mario , Patel Neel

Objective: Evidence shows type 1 diabetes leads to vascular damage and neuropathy. The purpose of this study was to perform a systematic review and a meta-analysis to asses the evidence of the effects of type 1 diabetes on hearing function.Methods: Three different electronic databases were used to identify eligible studies including a manual searching of references. The articles obtained were independently reviewed by two authors using predefined inclusi...

ea0066oc4.4 | Oral Communications 4 | BSPED2019

A novel clinical risk score that accurately predicts recurrence of craniopharyngioma – a multicentre cohort study

Kyprianou Nikolina , Blackburn James , Tan Rachael , Korbonits Marta , Dattani Mehul , Dutta Pinaki , Bhansali Anil , Rai Ashutosh , Ribalta Teresa , Bulfamante Gaetano Pietro , Massa Valentina , Roncaroli Federico , Evanson Jane , Skoric Tanja , Kastelan Darko , Gnanalingham Kanna , Mitchell Rod , Bulfamante Antonio Mario , Argente Jesus , Goycoolea Andres , Torales Jorge , Biagetti Betina , Audi Laura , Resmini Eugenia , Webb Susan M , Kapoor Ritika R , Chandler Christopher , Sampron Nicolas , Preda Cristina , Ahmad Amar , Gevers Evelien F Pease , Gaston-Massuet Carles

Introduction: Craniopharyngiomas (CPs) are histologically benign tumours but are clinically associated with significant morbidity and mortality. Recurrence of CPs is known to influence mortality, but apart from the extent of surgical resection, no clinical characteristics have been shown to predict recurrence. Complete resection is difficult due to their infiltrative behaviour and unacceptable morbidity. Thus, predictors of risk of recurrence are needed....